Estates of the Desceased Can File a Zantac Cancer Lawsuit

It is hard to know how many people have died from cancer after using Zantac regularly for an extended number of years

Thursday, January 21, 2021 - Stomach, bladder, and other cancer have a latency period of about 10 years before one starts to feel the painful symptoms of the disease and realize they have a problem. The only way to tell how many people have allegedly died from taking Zantac may be to count the number of estates that file suit against Sanofi, the maker of Zantac, claiming a loved one died allegedly as a result. Zantac has been for sale for more than 20 years and was the best-selling heartburn and acid reflux medicine available by prescription and over the counter. Zantac was recalled by the FDA, as were all other brands of ranitidine on April 1, 2020, after elevated levels of N-nitrosodimethylamine (NDMA), a cancer-causing compound, were discovered. NDMA is a known carcinogen and banned in the US. The FDA has been aware that ranitidine contained NDMA for decades and put a cap of 96 NGS per tablet as being safe. Online testing pharmacy Valisure found elevated NDMA in every Zantac test they performed, and over 3 million NGS in some.

Another alleged Zantac death was added to the over 500 current lawsuits filed by the loved ones of those who have died. According to NewYorkExaminer, "A Louisiana woman has filed a new Zantac lawsuit in the Superior Court of the State of Delaware. As the heir and surviving spouse of the deceased plaintiff, she claims that Zantac is unreasonably dangerous and caused the death of her spouse. According to her complaint, the decedent purchased and ingested Zantac (ranitidine), which was manufactured, marketed, and sold by the defendants. The plaintiff claims that as a result of taking the stomach acid-reducing drug, her husband developed cancer and died."

Cases like the one above have been gathered together from each state and consolidated into multidistrict litigation in federal court. The purpose of grouping them is to streamline repetitive court proceedings such as discovery. A federal judge is expected to hold Daubert hearings soon to get to the bottom of the cause or causes that make Zantac carcinogenic. Experts believe that ranitidine may be unstable and deteriorate without any other reason like interacting with stomach nitrates or being stored at higher than average room temperatures. Thousands of plaintiffs, many of whom will be the estates of those who have died, will file lawsuits in the months to come. If you or a loved one have died from cancer and had taken Zantac regularly you could have a case to file a claim seeking lump-sum monetary damages.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.